Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 42 non-cytoplasmic 43 65 transmembrane 66 93 cytoplasmic 94 119 transmembrane 120 149 non-cytoplasmic 150 168 transmembrane 169 179 cytoplasmic 180 202 transmembrane 203 221 non-cytoplasmic 222 246 transmembrane 247 257 cytoplasmic 258 280 transmembrane 281 305 non-cytoplasmic 306 333 transmembrane 334 348 cytoplasmic 349 371 transmembrane 372 390 non-cytoplasmic 391 408 transmembrane 409 425 cytoplasmic 426 452 transmembrane 453 457 non-cytoplasmic 458 476 transmembrane 477 486 cytoplasmic
Input: >GFF3445 FitnessBrowser__psRCH2:GFF3445 MTREKPKNLWLSRWGFILAATGSAVGLGNIWKFPYITGEFGGGAFVLMYLLCILAIGVPV MMCEIAIGRRGRGSPIDAIGRVVRENNGNPLWKAVGGMAMTAGFLILCFYVVVAGWAFAY TVKMLDGSLAATSVEALGGVFEAHNSNPWQLGGWSLLVALLTLWIVAKGVQKGIENAVRW MMPGLAVLLLILVGYAVTSGGFDQGFAFLFSFDTSKITGEALLAALGHAFFTLSLASGAI LTYGSYIPDDQSIARTTFMVAIADTCVALLAGLAIFPIIFANGMDPTAGPGLIFMSLPLA FQQMPFGTAFGVLFFAMVSIAALTSAISMIEATVAYLNEKHGISRLKAAMGSGAVLLVIS MLAMLSFNLMSGWTPMGKNFFDWLDYLTSRWMMPLGGIFTVLLAGYALRSEIMRDELNLP PLGYALWLFMVRYVCPVLILMVFLHALGWLGFDPLQRWYWIAGAIGALTLVGELLRPRVM PALAGR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server